Loading stock data…
ASTH
$38.47+0.08 (+0.21%)
Market OpenUpdated 3:39 PM EDT
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Astrana Health, Inc. in the Healthcare sector is trading at $38.47 with a market capitalization of $1.8B. Wall Street consensus targets $46.00 (9 analysts), implying a +19.6% move over the next 12 months. The stock is currently near its 52-week high of $39.93, remaining 37.3% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +19.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$38.47
Potential Downside
41.1%
Whystock Fair Value$22.66
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.82B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
60.16
Beta
Defensive asset. Lower volatility than the S&P 500.
0.99
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.78%
Volume
Today's trading volume
328,097
Recent News
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health (NASDAQ:ASTH) and its peers.
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)?
Earlier in May 2026, Astrana Health reported first-quarter revenue of US$965.1 million and net income of US$14.44 million, reaffirmed its 2026 revenue outlook, announced Chief Medical Officer Dinesh Kumar’s pending resignation, and named George Christides as Interim National Medical Director to oversee population health initiatives. Astrana Health and the Physician Association of California also revealed a collaboration that plugs independent primary care practices into Astrana’s in-house,...
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
2 Mooning Stocks Worth Investigating and 1 We Question
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.